Latest Quarterly Results
Quarter Ended August 1, 2020
(35.1%)
Comparable sales decline of (34.7%) on an owned basis; comparable sales decline of (35.1%) on an owned plus licensed basis.
$3.6B
Net Sales
($0.81)
Diluted EPS of ($1.39); ($0.81) per share excluding restructuring, impairment, settlement charges and other costs.
Source:
For complete information regarding our financials, see our periodic filings.
Latest Financial Results
Q2 2020
Quarter Ended Aug 1, 2020